Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I will conduct an S&P Global stock analysis and discuss the risks and upside potential of SPGI stock.

1 extracted signal · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
24 Sept 2025, 22:06 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Friends! In this video, I will conduct an S&P Global stock analysis and discuss the risks and upside potential of SPGI stock.
Source overview

AI-generated source summary

The analysis assesses S&P Global (SPGI), noting its 9% decline in the last 5 days and 10% decline this past month. SPGI makes money from 5 different segments. The analysis points out to S&P Dow Jones Indices which have 20 trillion USD indexed or benchmarked with $27.7 trillion indexed to all the S&P Dow Jones Industries. The credit rating business generates high margins. The business makes money from commodity insights. The mobility with Carfax delivers the best performance. SPGI has good earning power, it grew revenue in prior period. Stock was trading at a 30-31 PE, which is expensive due to the poor revenue growth, current PE is 28. The stock competes in certain data with Factset, but with an average PE of almost 30 and revenue that is only expected to grow 11-12% it would be appropriate for the stock to drop below 400.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
1
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
100%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
355
Historical success
34.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail